Liquen Plano Oral Erosivo: Presentación Clínica y Manejo Basado en Casos Clínicos.
Perspectiva Dermatológica · 2026
DOI: 10.66124/pd.v1i1.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perspectiva Dermatológica, 2026. Verfasst von Bruno Pardo-Ortiz und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Erosive oral lichen planus (EOLP) is a subtype of oral lichen planus characterized by chronic, painful ulcerative lesions primarily affecting the mucous membranes and, less commonly, the skin. Although the exact etiology remains unknown, current evidence suggests an autoimmune pathogenesis mediated by CD8+ cytotoxic T lymphocytes, which target and induce apoptosis in basal keratinocytes of the oral epithelium. EOLP predominantly affects the oral and genital mucosa, though involvement of other mucosal surfaces has been reported. The condition may coexist with other clinical variants of lichen planus and has been associated with drug exposure, autoimmune comorbidities, and micronutrient deficiencies. Diagnosis is based on characteristic clinical findings, supported by histopathological examination. Biopsy is essential not only to confirm the diagnosis but also to exclude epithelial dysplasia or malignant transformation. The chronic course of the disease, frequent relapses, and suboptimal therapeutic response make management particularly challenging. Topical corticosteroids are the first-line treatment and remain the cornerstone of therapy. In patients with inadequate response or extensive lesions, second-line agents such as topical calcineurin inhibitors (e.g., tacrolimus or pimecrolimus) may be employed. In severe or refractory cases, systemic treatments including oral corticosteroids (e.g., prednisone) and other immunomodulatory agents may be indicated. Emerging evidence highlights the importance of assessing and correcting nutritional deficiencies, particularly vitamin B12, folic acid, and iron, as a significant proportion of patients present with these abnormalities. Nutrient supplementation has been associated with clinically meaningful symptom improvement.Importantly, approximately 1% of EOLP cases may undergo malignant transformation to oral squamous cell carcinoma, underscoring the need for regular long-term monitoring. Additionally, mucosal scarring is a frequent complication, which may lead to functional impairments affecting alimentation, urination, and sexual activity.
Zitieren
APA
Pardo-Ortiz, B., Carpio, C. R. D., Orrego, G. V., & Chian-García, C. (2026). Liquen Plano Oral Erosivo: Presentación Clínica y Manejo Basado en Casos Clínicos. Perspectiva Dermatológica. https://doi.org/10.66124/pd.v1i1.10
Vancouver
Pardo-Ortiz B, Carpio CRD, Orrego GV, Chian-García C. Liquen Plano Oral Erosivo: Presentación Clínica y Manejo Basado en Casos Clínicos. Perspectiva Dermatológica. 2026. doi:10.66124/pd.v1i1.10
BibTeX
@article{PardoOrtiz2026,
author = {Pardo-Ortiz, Bruno and Carpio, Carmen Rojas Del and Orrego, Gladys Vidarte and Chian-García, César},
title = {Liquen Plano Oral Erosivo: Presentación Clínica y Manejo Basado en Casos Clínicos},
journal = {Perspectiva Dermatológica},
year = {2026},
doi = {10.66124/pd.v1i1.10}
}
EUVIMED